A looming anti-China biotechnology bill has spooked U.S. life sciences companies, according to a new report.The report by the China-based L.E.K. Consulting quantifies what until now has been mostly a vibe check. At this year’s Biotechnology Innovation Organization’s international conference, multiple biotech companies told STAT they plan to switch from striking deals with Chinese companies […]
